Antiepileptic Drugs Up Mortality Risk in Patients With Alzheimer's disease

Drugs used for seizures increase the risk of mortality in patients with Alzheimer's disease.The risk is higher in the first three months of treatment and among users of older antiepileptic drugs.

Antiepileptic drugs raise the risk of death among persons with Alzheimer’s disease, according to a new study from the University of Eastern Finland, published in Neurology.

The mortality risk increased considerably during the first three months of treatment with antiepileptic drugs, and was higher among users of older antiepileptic drugs in comparison to users of newer antiepileptics. The risk of death remained elevated after exclusion of people with epilepsy in the sensitivity analyses.

‘New study results highlight warning in prescribing antiepileptic drugs for indications other than epilepsy in Alzheimer's disease vulnerable patients.’
Read More..

The increased risk remained after controlling for comorbidities, sociodemographic factors and the use of other drugs. However, it is possible that the reasons for initiating an antiepileptic partially explain the results and, therefore, the findings should be confirmed in further studies.

These initial findings are concerning, as people with Alzheimer’s disease used antiepileptic drugs more frequently than people without the disease, and the use of older antiepileptics is more common among them. The association between antiepileptic use and mortality in this population has not been studied before.

The results highlight caution in prescribing these drugs for indications other than epilepsy in this vulnerable group. Up to 1% of the population needs chronic antiepileptic treatment to control epilepsy.

These drugs are also frequently used for other indications, including neuropathic pain and behavioural and psychological symptoms of dementia, although antiepileptics are not officially indicated for behavioural and psychological symptoms of dementia.

The studies are based on the Finnish nationwide MEDALZ dataset, which includes all community-dwelling persons with Alzheimer’s disease in Finland during 2005-2011 (70,718 people). Data on antiepileptic drug use was extracted from the Prescription Register.

Mothers Taking Antiepileptic Drugs can Safely Breastfeed
Breastfeeding is associated with benefits for children and their mothers. However, when mothers take medications there is a potential for adverse side effects in the infant. But, anti epileptics may not harm the baby.

The mortality risk was compared between antiepileptic drug users and matched non-users with Alzheimer’s disease. The study, funded by the Academy of Finland, was conducted at the University of Eastern Finland.

Source-Eurekalert